ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 137 filers reported holding ANAPTYSBIO INC in Q4 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $315,845 | -55.9% | 17,586 | -50.0% | 0.00% | – |
| Q2 2023 | $715,907 | +838.9% | 35,197 | +904.5% | 0.00% | – |
| Q1 2023 | $76,247 | -95.2% | 3,504 | -93.2% | 0.00% | -100.0% |
| Q4 2022 | $1,605,003 | +487.9% | 51,791 | +384.3% | 0.00% | – |
| Q3 2022 | $273,000 | -39.2% | 10,694 | -51.7% | 0.00% | – |
| Q2 2022 | $449,000 | -62.1% | 22,125 | -53.8% | 0.00% | – |
| Q1 2022 | $1,186,000 | +28.5% | 47,941 | +80.5% | 0.00% | – |
| Q4 2021 | $923,000 | +21.8% | 26,566 | -5.0% | 0.00% | – |
| Q3 2021 | $758,000 | +501.6% | 27,961 | +476.6% | 0.00% | – |
| Q2 2021 | $126,000 | -86.1% | 4,849 | -88.5% | 0.00% | – |
| Q1 2021 | $905,000 | +2413.9% | 41,990 | +2444.8% | 0.00% | – |
| Q4 2020 | $36,000 | +414.3% | 1,650 | +239.5% | 0.00% | – |
| Q3 2020 | $7,000 | -56.2% | 486 | -31.2% | 0.00% | – |
| Q2 2020 | $16,000 | +33.3% | 706 | -17.3% | 0.00% | – |
| Q1 2020 | $12,000 | -47.8% | 854 | -38.9% | 0.00% | – |
| Q4 2019 | $23,000 | -98.2% | 1,397 | -96.2% | 0.00% | -100.0% |
| Q3 2019 | $1,303,000 | +21.1% | 37,225 | +95.4% | 0.00% | – |
| Q2 2019 | $1,076,000 | +218.3% | 19,055 | +312.3% | 0.00% | – |
| Q1 2019 | $338,000 | -86.5% | 4,622 | -88.3% | 0.00% | -100.0% |
| Q4 2018 | $2,513,000 | +74.8% | 39,384 | +173.2% | 0.00% | 0.0% |
| Q3 2018 | $1,438,000 | +470.6% | 14,415 | +307.0% | 0.00% | – |
| Q2 2018 | $252,000 | -95.0% | 3,542 | -92.8% | 0.00% | -100.0% |
| Q1 2018 | $5,087,000 | +227.6% | 48,878 | +217.0% | 0.00% | +100.0% |
| Q4 2017 | $1,553,000 | +1484.7% | 15,417 | +450.0% | 0.00% | – |
| Q3 2017 | $98,000 | +22.5% | 2,803 | -16.4% | 0.00% | – |
| Q2 2017 | $80,000 | +2566.7% | 3,351 | +2865.5% | 0.00% | – |
| Q1 2017 | $3,000 | – | 113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
| EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
| GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
| Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
| Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
| Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
| Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
| Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
| TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
| Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |